Ocaliva (obeticholic acid) is a prescription drug for Primary Biliary Cholangitis (PBC) that has come under intense legal scrutiny due to its links to severe liver injury, FDA warnings, and allegations against its manufacturer. Understanding your rights and potential legal options if you’ve been affected by Ocaliva is essential—this comprehensive guide from AWKO explains the details, risks, and next steps.
What is Ocaliva?
- Ocaliva (obeticholic acid) is a prescription medication indicated for Primary Biliary Cholangitis (PBC), a rare and chronic liver disease characterized by progressive destruction of the bile ducts within the liver.
- The drug is primarily prescribed when the standard treatment with ursodeoxycholic acid (UDCA) fails or is not tolerated.
- Ocaliva is designed to slow the progression of liver damage, decrease inflammation, and improve biochemical markers of PBC.
The FDA’s Stance: The Black Box Warning
- Ocaliva has been the subject of intense regulation following reports of dangerous side effects, primarily severe liver injury and death.
- In 2018, the FDA added a Black Box Warning—their strongest warning—to Ocaliva due to serious incidents of liver decompensation and failure, especially when incorrectly dosed.
- The Black Box Warning specifically cautions against overdosing in patients with moderate or severe liver impairment and mandates close monitoring of any patient with declining liver function.
- The FDA continues to monitor Ocaliva and restricts its use in patients with advanced cirrhosis or those displaying signs of liver failure.
Key Safety Issues
- The risk of liver injury exists even in those who receive the recommended dose, but overdosing—especially daily instead of weekly dosing in high-risk patients—elevated the likelihood of life-threatening complications.
- Reports from the FDA indicate at least nineteen deaths and eleven serious cases of liver injury linked to Ocaliva in the initial years after its approval.
- Healthcare professionals are required to calculate a Child-Pugh score for all PBC patients to determine the correct starting dosage and must routinely monitor biochemical response and disease progression.
The Allegation: Manufacturer Liabilities
- Ocaliva’s manufacturer, Intercept Pharmaceuticals, is facing lawsuits with multiple allegations:
- Failure to adequately warn both healthcare providers and patients about the severity and frequency of liver-related risks, leaving many unaware of potential life-threatening dangers.
- Downplaying risk data in marketing materials and FDA submissions, and failing to update labeling or conduct post-market surveillance when signals of harm emerged.
- Presenting potentially misleading safety information leading to delayed recognition of the drug’s risks both in clinical settings and public communications.
- Lawsuits also cite “failure to warn” and “negligence,” seeking damages related to medical expenses, lost wages, pain and suffering, and, in wrongful death cases, the loss of companionship and funeral costs.
Who May Have a Case?
You may be eligible to file an Ocaliva lawsuit if you meet criteria such as:
- Diagnosis of liver failure, cirrhosis, or severe liver damage after taking Ocaliva for PBC.
- Suffering significant medical complications (such as the need for liver transplant) linked to Ocaliva use.
- Documentation showing Ocaliva was prescribed and taken during a period when adverse effects were developing.
- Experience of additional damages, including medical bills, disability, pain and suffering, lost wages, funeral or burial expenses (in the case of wrongful death), and loss of companionship.
How to Prove a Case
To succeed in an Ocaliva-related lawsuit, plaintiffs must generally show:
- That the drug was prescribed and taken as directed or per FDA guidance.
- Medical records demonstrating onset of severe liver injury or progression to advanced cirrhosis after starting Ocaliva.
- Evidence that damages were incurred as a direct result of Ocaliva’s side effects (medical and financial), which may require testimony from medical experts and a thorough review of pharmaceutical records.
- That the manufacturer failed to provide adequate warnings or updated guidance in a timely manner, contributing to the injury or loss.
Legal Process & What to Expect
- Filing a lawsuit usually starts with a free, confidential case review with an experienced Ocaliva attorney to assess your claim, timeline, and available evidence.
- Your lawyer will review pharmacy records, prescription details, medical history, and the circumstances of liver injury.
- If your claim is accepted, the legal process will include expert medical testimony, evidence collection, and negotiations with Intercept Pharmaceuticals or its insurers.
- Many cases are consolidated as part of larger multi-district litigation, making individual voices and documented harms more impactful for settlements or trial.
What Are Your Legal Rights?
Drug defect lawsuits are complex, but patients harmed by Ocaliva may have rights to:
- Recover monetary compensation for medical costs, lost wages, and ongoing care.
- Seek damages for pain, suffering, and long-term disability caused by the drug.
- Pursue compensation in wrongful death cases for funeral costs and the loss of relationships and support, making litigation a crucial avenue for families impacted by Ocaliva’s risks.
- Hold manufacturers accountable to promote safer pharmaceutical standards and increase transparency in drug warnings and labeling.
Frequently Asked Questions
- Is Ocaliva still prescribed?
- As of late 2025, Ocaliva has faced withdrawals and intense legal and FDA scrutiny, but some prescriptions remain, primarily for patients who require alternative therapies for PBC.
- What should I do if I took Ocaliva and suffered liver problems?
- Seek immediate medical attention and request a thorough evaluation by a liver specialist if you have experienced symptoms such as jaundice, abdominal pain, swelling, fatigue, or unexplained bleeding.
- Contact a qualified Ocaliva lawyer (such as those at AWKO) for a confidential, free consultation to understand your rights and potential for compensation.
- Who can file an Ocaliva lawsuit?
- Anyone who was prescribed Ocaliva, suffered serious liver complications or cirrhosis, and can provide medical evidence of harm linked to the drug may qualify. Families who lost loved ones due to PBC progression while on Ocaliva may also be eligible.
Your Next Step: Speak to an Ocaliva Attorney
If you or a loved one suffered liver failure, cirrhosis, severe injury, or wrongful death after taking Ocaliva, the team at AWKO can help determine your legal rights and options for compensation. Our attorneys have deep experience in pharmaceutical litigation and can guide you through every step of the process.
Contact AWKO for a Free, Confidential Case Evaluation
- No upfront costs
- No obligation
- Compassionate, expert guidance from experienced drug injury attorneys
Call AWKO Law today or fill out a contact form to speak with a legal professional specializing in Ocaliva injury cases.
Protect your health, your family, and your rights—don’t wait. You may be entitled to significant compensation.